期刊文献+

雄激素受体在前列腺癌细胞激素非依赖转化中的表达及调控 被引量:5

Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells
下载PDF
导出
摘要 目的:研究雄激素受体(androgen receptor,AR)在激素依赖性前列腺癌(androgen dependent prostate can-cer,ADPC)细胞系LNCaP转化成激素非依赖性前列腺癌(androgen independent prostate cancer,AIPC)过程中的表达变化,以及其受Wnt信号通路和蛋白酶体降解通路调控的机制。方法:应用活性炭滤过的低激素胎牛血清培养LNCaP细胞,得到雄激素非依赖的LNCaP亚系LNCaP-AI(androgen independent)细胞。应用细胞增殖试验检测LNCaP-AI的细胞生长曲线。应用Western blot、RT-PCR分析激素依赖性转化过程中的AR、前列腺特异抗原(pros-tate specific antigen,PSA)的表达变化。在AIPC细胞中,应用Wnt信号通路阻滞剂IWR-1及蛋白酶体通路抑制剂乳胞素(lactacystin)处理细胞,观察Wnt信号通路和蛋白酶体信号通路对AR mRNA及蛋白表达的影响。结果:在体外低激素环境中生长6个月后,LNCaP细胞变成雄激素非依赖性的LNCaP亚系LNCaP-AI。表现为对雄激素依赖性减弱,细胞增殖加快,PSA的表达增高。在转化为LNCaP-AI的过程中,AR mRNA水平短期上调,后恢复到原始水平,但蛋白水平一直处于下调趋势。IWR-1处理的LNCaP-AI,AR mRNA及蛋白的表达下调。乳胞素处理的LNCaP-AI,AR mRNA无变化而蛋白表达上调。结论:在体外前列腺癌细胞由激素依赖性向非依赖性转化的过程中,AR mRNA表达仅有一过性增高,而蛋白表达呈现明显的下降趋势。进一步研究发现,Wnt信号通路和蛋白酶体通路可能对AR的蛋白表达有调控作用。Wnt信号通路的抑制或蛋白酶体信号通路的增强可能是AR蛋白表达下调的原因。 Objective: To investigate the expression and regulation of androgen receptor(AR) in prostate cancer cells from androgen dependent to androgen independent.Methods: LNCaP cells were cultured in charcoal-stripped serum for 6 months to establish androgen-independent celline(LNCaP-AI).Proliferation of LNCaP-AI was assayed by cell viability.Expression of AR mRNA and protein was analyzed by RT-PCR and Western blot.Wnt signaling pathway inhibitor IWR-1 and proteasome inhibitor lactacystin were used to investigate effects of Wnt and proteasome pathway on AR expression in LNCaP-AI.Results: LNCaP-AI exhibit enhanced proliferation and up-regulated PSA expression compared with LNCaP.During androgen deprivation,AR mRNA was up-regulated in a short early stage and then declined to a stable level in LNCaP-AI compared with LNCaP,but AR protein kept in downward trend.The mRNA and protein expression of AR was decreased by IWR-1 treatment.AR protein but not mRNA was increased by lactacystin treatment.Conclusion: The androgen independent prostate cancer cellline was established by androgen deprivation,in which the protein expression of AR was dramatically decreased.mRNA and protein expression of AR in LNCaP-AI was related to Wnt signaling pathway and proteasome pathway.Increased Wnt signaling or decreased proteasome pathways contribute the decreased AR protein expression.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2011年第4期490-495,共6页 Journal of Peking University:Health Sciences
基金 国家自然科学基金项目(30772168)资助~~
关键词 受体 雄激素 前列腺肿瘤 肿瘤 激素依赖性 Receptors androgen Prostatic neoplasms Neoplasms hormone-dependent
  • 相关文献

参考文献25

  • 1Miyamoto H, Messing EM, Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects [ J]. Prostate, 2004, 61 (4) : 332 - 353.
  • 2Yang X, Chen MW, Terry S, et al. Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells [J]. Oncogene, 2006, 25(24): 3436-3444.
  • 3Shi XB, Ma AH, Tepper CG, et al. Molecular alterations associated with LNCaP cell progression to androgen independence [ J]. Prostate, 2004, 60(3): 257-271.
  • 4Chen MW, Vacherot F, De La Taille A, et al. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer ceils [J]. Oncogene, 2002, 21 (51) : 7861 -7871.
  • 5Yang XZ, Chen MW, Terry S, et al. A human-and male-specific protocadherin that acts through the Wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells [J]. Cancer Res, 2005, 65(12) : 5263 -5271.
  • 6Zhang L, Altuwaijri S, Deng F, et al. NF-kappa B regulates androgen receptor expression and prostate cancer growth [ J ]. Am J Pathol, 2009, 175(2) : 489 -499.
  • 7Yang L, Xie S, Jamaluddin MS, et al. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3 a, and their roles in apoptosis of LNCaP prostate cancer cells [J]. J Biol Chem, 2005,280(39) : 33558 -33565.
  • 8Alimirah F, Panchanathan R, Chen J, et al. Expression of androgen receptor is negatively regulated by p53 [ J]. Neoplasia, 2007, 9(12) : 1152 -1159.
  • 9Chiu HH, Yong TM, Wang J, et al. Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer [J]. Cancer Lett, 2010, 292(2) : 176-185.
  • 10Kudahetti S, Fisher G, Ambroisine L, et al. p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer [J]. BJU Int, 2009, 104(1) : 20 -24.

同被引文献44

  • 1潘寿华,阎家峻,郑专.前列腺癌雄激素依赖转化后雄激素受体基因表达变化的研究[J].中国癌症杂志,2011,21(4):287-289. 被引量:3
  • 2洪宝发,蔡伟,符伟军,杨勇,王威,陈耀富,展洁,张翠娥,李炎唐,崔胜堂.选择性绿激光汽化术治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志,2005,26(1):17-19. 被引量:90
  • 3丁涛,车文骏,陈同珏.前列腺癌组织中性激素受体表达的分析[J].中华男科学杂志,2006,12(1):50-52. 被引量:9
  • 4甘道举,江军,陈善勤,赖建平,王学华,孙广运,牟江洪.雄激素受体在雄激素非依赖性前列腺癌的表达[J].临床泌尿外科杂志,2006,21(4):279-281. 被引量:11
  • 5BASU GD,AZORSA DO,KIEFER JA,et al.Functional evidence implicating S100P in prostate cancer progression[J].Int J Cancer,2008,123,330-339.
  • 6HAMADA S,SATOH K,HIROTA M,et al.Calciumbinding protein S100P is a novel diagnostic marker of cholangiocarcinoma[J].Cancer Sci,2011,102(1):150-156.
  • 7LOGSDON CD,SIMEONE DM,BINKLEY C,et al.Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer[J].Cancer Res,2003,63(12):2649-2657.
  • 8DIEDERICHS S,BULK E,STEFFEN B,et al.S100 family members and trypsinogens are predictors of distant metastasis and survival in earlystage nonsmall cell lung cancer[J].Cancer Res,2004,64(16):5564-5569..
  • 9FUENTES MK,NIGAVEKARS S,ARUMGAM T,et al.RAGE activation by S100P in colon cancer stimulates growth,migration,and cell signaling pathways[J].Dis Colon Rectum,2007,50(8):1230-1240.
  • 10HIGGINS JP,KAYGUSUZ G,WANG L,et al.Placental S100(S100P) and GATA3:markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray[J].Am J Surg Pathol,2007,31(5):673-680.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部